Evotec SE (EVO) Return on Sales [ROS] (2009 - 2026)
Evotec SE's Return on Sales [ROS] was 14.92% in the quarter ended Dec 31, 2025, up 12.39 percentage points from 2.53% a year earlier and up 42.08 percentage points from the prior quarter.
Powered by 
Analysis
Evotec SE (EVO) Return on Sales [ROS] (2009 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Return on Sales [ROS] at Evotec SE came in at -0.01%, up 17.87 percentage points from the prior year.
- Return on Sales [ROS] shows a five-year change of -9.70 percentage points (years ended Dec 2020 to Dec 2025).
- In earlier years, Return on Sales [ROS] was -17.88% in the year ended Dec 31, 2024 (-11.80 pp), -6.08% in the year ended Dec 31, 2023 (-8.85 pp), 2.77% in the year ended Dec 31, 2022 (-3.86 pp) and 6.63% in the year ended Dec 31, 2021 (-3.06 pp).
- The figure for the quarter ended Dec 31, 2025 marks the highest quarterly Return on Sales [ROS] since the quarter ended Mar 31, 2022.
- Compared with a year earlier, Return on Sales [ROS] was higher in two of the last seven quarters, with an average year-over-year change of -3.54 percentage points.
- The best year-over-year quarter for Return on Sales [ROS] over five years was the quarter ended Jun 30, 2025 (a gain of 38.87 percentage points); the worst was the quarter ended Sep 30, 2022 (a drop of 11102.01 percentage points).
- Per Business Quant data, EVO's Return on Sales [ROS] in the three quarters before the quarter ended Dec 31, 2025 was -27.15% (quarter ended Sep 30, 2025), -16.22% (quarter ended Jun 30, 2025) and -10.01% (quarter ended Mar 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 45.36 Bn | 36.74 Bn | 1.50 Bn | 12.92% |
| 2 | Medpace Holdings | 18.58 Bn | 16.23 Bn | 223.89 Mn | 23.12% |
| 3 | Charles River Laboratories International | 16.56 Bn | 15.80 Bn | 357.87 Mn | 20.62% |
| 4 | Icon | 15.67 Bn | 12.44 Bn | 491.83 Mn | 9.82% |
| 5 | Fortrea Holdings | 2.06 Bn | 1.35 Bn | 139.50 Mn | 2.17% |
| 6 | Ginkgo Bioworks Holdings | 774.61 Mn | 39.09 Mn | 25.91 Mn | -157.46% |
| 7 | Evotec SE | 600.89 Mn | -1.16 Bn | - | - |
| 8 | Champions Oncology | 66.11 Mn | 41.77 Mn | 7.70 Mn | -2.69% |
| 9 | MindWalk Holdings | 48.11 Mn | 11.77 Mn | 1.61 Mn | -159.86% |
| 10 | Natural Alternatives International | 6.27 Mn | -21.81 Mn | 1.73 Mn | -38.18% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -77.50% |
| Dec 31, 2025 | 14.92% |
| Sep 30, 2025 | -27.15% |
| Jun 30, 2025 | -16.22% |
| Mar 31, 2025 | -10.01% |
| Dec 31, 2024 | 2.53% |
| Sep 30, 2024 | -14.33% |
| Jun 30, 2024 | -57.44% |
| Mar 31, 2024 | -8.72% |
| Dec 31, 2023 | 5.86% |
| Sep 30, 2023 | -6.21% |
| Jun 30, 2023 | -16.99% |
| Dec 31, 2022 | 15.66% |
| Sep 30, 2022 | -7.78% |
| Jun 30, 2022 | -2.19% |
| Mar 31, 2022 | 281.16% |
| Dec 31, 2021 | 0.01% |
| Sep 30, 2021 | 11,109.79% |
| Jun 30, 2021 | 1.11% |
| Mar 31, 2021 | 5,092.99% |
API Access
Evotec SE Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=EVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "EVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=EVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();